Cancer incidence and mortality in France over the 1980–2012 period: Solid tumors

Binder-Foucard, F.; Bossard, Nadine; Delafosse, Patricia; Belot, Aurélien; Woronoff, Anne‐Sophie; Remontet, Laurent

doi:10.1016/j.respe.2013.11.073

Cited by 202 publications

(157 citation statements)

References 33 publications

Supporting

Mentioning

146

Contrasting

Unclassified

Order By: Relevance

“…As previously described by ALBERG et al [4] the proportion of women increased significantly over time from 24.1 to 30%. This increase is linked to the prevalence of cigarette smoking which peaked two decades earlier in men than in women [3,4,19].…”

Section: Discussionmentioning

confidence: 99%

“…In Europe, lung cancer is the leading cause of death by cancer with around 260 000 deaths in 2011 [2]. In France, the incidence and mortality rates were respectively 51.7 and 37.0 per 100 000 person-years in men and 18.6 and 12.9 in women, and around 30 000 people died from lung cancer in 2012 [3]. The incidence in men started to decrease in 2005, while it increased significantly by approximately 5.3% per year between 1980 and 2005 in women [3].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Time trends in surgery for lung cancer in France from 2005 to 2012: a nationwide study

Morgant

Pagès

Orsini³

et al. 2015

Eur Respir J

View full text Add to dashboard Cite

The aim of this study was to assess the evolution of survival in patients treated surgically for non-small cell lung cancer (NSCLC) between 2005 and 2012.From January 2005 to December 2012, 34 006 patients underwent pulmonary resection for NSCLC and were included in the French national database Epithor. Patients' characteristics, procedures and survival were analysed. Survival according to the management was evaluated for each 2-year period separately: 2005-2006, 2007-2008, 2009-2010 and 2011-2012.The proportions of early-stage cancers and adenocarcinomas increased significantly over the periods. 3-year overall survival (OS) increased significantly from 80.5% for the first period to 81.4% for the last period. For the periods 2005-2006 and 2007-2008, 3-year OS was lower after segmentectomy than after lobectomy (77 and 73% versus 82 and 83%, respectively). For the periods 2009-2010 and 2011-2012, 3-year OS in the two sub-groups was similar. OS after bi-lobectomy or pneumonectomy was lower than after lobectomy for all periods analysed. Systematic nodal dissection increased OS for all periods. Chemotherapy but not radiotherapy improved OS in the first 12 postoperative months for all periods.Changes in histological type and stage linked to advances in surgical and medical practices since 2005 led to an increase in OS in patients with surgical-stage NSCLC. @ERSpublications Overall survival and postoperative mortality after lung cancer surgery improve over the last decades

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Time trends in surgery for lung cancer in France from 2005 to 2012: a nationwide study

Morgant

Pagès

Orsini³

et al. 2015

Eur Respir J

View full text Add to dashboard Cite

show abstract

“…Thyroid cancer is the most common endocrine malignancy, and in recent decades, its incidence has shown a steady increase [1]. Thyroid cancer generally carries a very good prognosis [2].…”

Section: Introductionmentioning

confidence: 99%

Intraoperative Near‐infrared Imaging for Parathyroid Gland Identification by Auto‐fluorescence: A Feasibility Study

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Colorectal cancer is the second most common type of cancer and the second cause of cancer-related death among French women after breast cancer (1). Environmental factors, particularly food habits, are believed to play a major role in its development (2).…”

Section: Introductionmentioning

confidence: 99%

Heme Iron Intake, Dietary Antioxidant Capacity, and Risk of Colorectal Adenomas in a Large Cohort Study of French Women

Bastide

Morois

Cadeau

et al. 2016

Cancer Epidemiology, Biomarkers &Amp; Prevention

View full text Add to dashboard Cite

Background: Nitrosylated and non-nitrosylated heme iron from red processed and nonprocessed meat have been associated with increased colorectal carcinogenesis. Mechanisms include oxidative processes. It has been hypothesized that dietary antioxidants could counteract the effects of heme iron. We investigated the relationships between heme iron intake and the risk of colorectal adenomas, and a potential interaction with the dietary antioxidant capacity, in the E3N prospective cohort study.Methods: The study included 17,397 women, who underwent at least one colonoscopy. Among them, 1,409 were diagnosed with at least one first colorectal adenoma during the 103,253 person-years of follow-up. Dietary intake was measured by a semiquantitative food history questionnaire. HR estimates and 95% confidence intervals (CI) were obtained from Cox proportional hazards models, adjusted for potential confounders.

show abstract

Cancer incidence and mortality in France over the 1980–2012 period: Solid tumors

Cited by 202 publications

References 33 publications

Time trends in surgery for lung cancer in France from 2005 to 2012: a nationwide study

Time trends in surgery for lung cancer in France from 2005 to 2012: a nationwide study

Intraoperative Near‐infrared Imaging for Parathyroid Gland Identification by Auto‐fluorescence: A Feasibility Study

Heme Iron Intake, Dietary Antioxidant Capacity, and Risk of Colorectal Adenomas in a Large Cohort Study of French Women

Contact Info

Product

Resources

About